196 related articles for article (PubMed ID: 25577552)
1. Expression of carbonic anhydrase 9 is a novel prognostic marker in resectable hepatocellular carcinoma.
Kang HJ; Kim IH; Sung CO; Shim JH; Yu E
Virchows Arch; 2015 Apr; 466(4):403-13. PubMed ID: 25577552
[TBL] [Abstract][Full Text] [Related]
2. CA9 overexpression is an independent favorable prognostic marker in intrahepatic cholangiocarcinoma.
Gu M
Int J Clin Exp Pathol; 2015; 8(1):862-6. PubMed ID: 25755787
[TBL] [Abstract][Full Text] [Related]
3. Expression of hypoxic marker carbonic anhydrase IX predicts poor prognosis in resectable hepatocellular carcinoma.
Huang WJ; Jeng YM; Lai HS; Fong IU; Sheu FY; Lai PL; Yuan RH
PLoS One; 2015; 10(3):e0119181. PubMed ID: 25738958
[TBL] [Abstract][Full Text] [Related]
4. Expression of carbonic anhydrase IX is associated with poor prognosis through regulation of the epithelial‑mesenchymal transition in hepatocellular carcinoma.
Hyuga S; Wada H; Eguchi H; Otsuru T; Iwgami Y; Yamada D; Noda T; Asaoka T; Kawamoto K; Gotoh K; Takeda Y; Tanemura M; Umeshita K; Doki Y; Mori M
Int J Oncol; 2017 Oct; 51(4):1179-1190. PubMed ID: 28849188
[TBL] [Abstract][Full Text] [Related]
5. Carbonic anhydrase 9 is associated with chemosensitivity and prognosis in breast cancer patients treated with taxane and anthracycline.
Aomatsu N; Yashiro M; Kashiwagi S; Kawajiri H; Takashima T; Ohsawa M; Wakasa K; Hirakawa K
BMC Cancer; 2014 Jun; 14():400. PubMed ID: 24893880
[TBL] [Abstract][Full Text] [Related]
6. Carbonic anhydrase 9 expression in well-differentiated pancreatic neuroendocrine neoplasms might be associated with aggressive behavior and poor survival.
Kim JY; Lee SH; An S; Kim SJ; Sung YN; Song KB; Hwang DW; Kim SC; Hong SM
Virchows Arch; 2018 May; 472(5):739-748. PubMed ID: 29666945
[TBL] [Abstract][Full Text] [Related]
7. Expression of carbonic anhydrase IX is associated with postoperative recurrence and poor prognosis in surgically treated oral squamous cell carcinoma.
Choi SW; Kim JY; Park JY; Cha IH; Kim J; Lee S
Hum Pathol; 2008 Sep; 39(9):1317-22. PubMed ID: 18440050
[TBL] [Abstract][Full Text] [Related]
8. 3'UTR polymorphisms of carbonic anhydrase IX determine the miR-34a targeting efficiency and prognosis of hepatocellular carcinoma.
Hua KT; Liu YF; Hsu CL; Cheng TY; Yang CY; Chang JS; Lee WJ; Hsiao M; Juan HF; Chien MH; Yang SF
Sci Rep; 2017 Jun; 7(1):4466. PubMed ID: 28667334
[TBL] [Abstract][Full Text] [Related]
9. Co-expression of VEGF and CA9 in ovarian high-grade serous carcinoma and relationship to survival.
Williams E; Martin S; Moss R; Durrant L; Deen S
Virchows Arch; 2012 Jul; 461(1):33-9. PubMed ID: 22699808
[TBL] [Abstract][Full Text] [Related]
10. Carbonic anhydrase IX expression, a novel surrogate marker of tumor hypoxia, is associated with a poor prognosis in non-small-cell lung cancer.
Swinson DE; Jones JL; Richardson D; Wykoff C; Turley H; Pastorek J; Taub N; Harris AL; O'Byrne KJ
J Clin Oncol; 2003 Feb; 21(3):473-82. PubMed ID: 12560438
[TBL] [Abstract][Full Text] [Related]
11. Carbonic Anhydrase IX is not a predictor of outcomes in non-metastatic clear cell renal cell carcinoma - a digital analysis of tissue microarray.
Zerati M; Leite KR; Pontes-Junior J; Segre CC; Reis ST; Srougi M; Dall'Oglio MF
Int Braz J Urol; 2013; 39(4):484-92. PubMed ID: 24054396
[TBL] [Abstract][Full Text] [Related]
12. Colocalization of carbonic anhydrase 9 expression and cell proliferation in human head and neck squamous cell carcinoma.
Hoogsteen IJ; Marres HA; Wijffels KI; Rijken PF; Peters JP; van den Hoogen FJ; Oosterwijk E; van der Kogel AJ; Kaanders JH
Clin Cancer Res; 2005 Jan; 11(1):97-106. PubMed ID: 15671533
[TBL] [Abstract][Full Text] [Related]
13. Circulating hypoxia marker carbonic anhydrase IX (CA9) in patients with hepatocellular carcinoma and patients with cirrhosis.
Finkelmeier F; Canli Ö; Peiffer KH; Walter D; Tal A; Koch C; Pession U; Vermehren J; Trojan J; Zeuzem S; Piiper A; Greten FR; Grammatikos G; Waidmann O
PLoS One; 2018; 13(7):e0200855. PubMed ID: 30011326
[TBL] [Abstract][Full Text] [Related]
14. Tumor-associated carbonic anhydrases are linked to metastases in primary cervical cancer.
Kim JY; Shin HJ; Kim TH; Cho KH; Shin KH; Kim BK; Roh JW; Lee S; Park SY; Hwang YJ; Han IO
J Cancer Res Clin Oncol; 2006 May; 132(5):302-8. PubMed ID: 16416108
[TBL] [Abstract][Full Text] [Related]
15. CA9 expression as a prognostic factor in renal clear cell carcinoma.
Soyupak B; Erdoğan S; Ergin M; Seydaoğlu G; Kuzgunbay B; Tansuğ Z
Urol Int; 2005; 74(1):68-73. PubMed ID: 15711113
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer.
Hussain SA; Ganesan R; Reynolds G; Gross L; Stevens A; Pastorek J; Murray PG; Perunovic B; Anwar MS; Billingham L; James ND; Spooner D; Poole CJ; Rea DW; Palmer DH
Br J Cancer; 2007 Jan; 96(1):104-9. PubMed ID: 17213826
[TBL] [Abstract][Full Text] [Related]
17. The impact of immunohistochemical staining with ezrin-carbonic anhydrase IX and neuropilin-2 on prognosis in patients with metastatic renal cell cancer receiving tyrosine kinase inhibitors.
Cetin B; Gonul II; Buyukberber S; Afsar B; Gumusay O; Algın E; Turan N; Ozet A; Benekli M; Coskun U
Tumour Biol; 2015 Nov; 36(11):8471-8. PubMed ID: 26026587
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic and prognostic significance of immunohistochemical expression of HIF-1α, CXCR4 and CA9 in colorectal carcinoma.
Saka B; Ekinci O; Dursun A; Akyurek N
Pathol Res Pract; 2017 Jul; 213(7):783-792. PubMed ID: 28554753
[TBL] [Abstract][Full Text] [Related]
19. Endogenous markers of two separate hypoxia response pathways (hypoxia inducible factor 2 alpha and carbonic anhydrase 9) are associated with radiotherapy failure in head and neck cancer patients recruited in the CHART randomized trial.
Koukourakis MI; Bentzen SM; Giatromanolaki A; Wilson GD; Daley FM; Saunders MI; Dische S; Sivridis E; Harris AL
J Clin Oncol; 2006 Feb; 24(5):727-35. PubMed ID: 16418497
[TBL] [Abstract][Full Text] [Related]
20. Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer.
Giatromanolaki A; Koukourakis MI; Sivridis E; Pastorek J; Wykoff CC; Gatter KC; Harris AL
Cancer Res; 2001 Nov; 61(21):7992-8. PubMed ID: 11691824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
